InsidersTradesSigma
基于 4 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the detailed record of transactions filed by Dayal Sujata Tyagi. Officer active across 1 company, notably Emergent BioSolutions Inc.. Cumulatively, 5 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €74k. Activity tracked since 21 July 2022. The latest transaction was filed on 7 November 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Dayal Sujata Tyagi is a declarant linked to Emergent BioSolutions Inc. as a Director. She has 4 filings in total, and the 4 sampled filings run from 2022-07-22 to 2025-05-02, with transactions identified as Attribution and buy and sell amounts of EUR 0 in this recent sample.